Modulation of the plasma cholesteryl ester transfer by stachybotramide

Area of Science:

• Biochemistry
• Lipid Metabolism
• Pharmacology

Background:

• Cholesteryl ester transfer protein (CETP) is crucial for reverse cholesterol transport, mediating lipid exchange between lipoproteins.
• Dysregulation of CETP activity is implicated in various cardiovascular diseases.
• Identifying modulators of CETP activity is essential for developing novel lipid-lowering therapies.

Purpose of the Study:

• To investigate the effect of the fungal metabolite stachybotramide on CETP activity.
• To determine the impact of stachybotramide on the transfer of cholesteryl esters and triglycerides between lipoproteins.

Main Methods:

• In vitro assays measuring the transfer of radiolabeled cholesteryl esters ([14C]CE) and triglycerides ([3H]TG) between human plasma lipoproteins.
• Assessment of stachybotramide's effect on CETP-mediated lipid transfer at varying concentrations.
• Confirmation of CETP involvement using anti-CETP antibodies.

Main Results:

• Stachybotramide significantly stimulated [14C]CE transfer from HDL to VLDL and LDL by 1.3- to 1.5-fold at 0.2-0.5 mM.
• This stimulation of CE transfer was dependent on CETP activity, as evidenced by abolition with anti-CETP antibody.
• Stachybotramide showed a slight reduction in [14C]CE transfer from LDL/VLDL to HDL and did not significantly affect [3H]TG transfer from HDL.

Conclusions:

• Stachybotramide preferentially stimulates CETP-mediated transfer of cholesteryl esters from HDL to VLDL and LDL.
• These findings suggest stachybotramide as a potential modulator of reverse cholesterol transport.
• Further research into stachybotramide's mechanism and therapeutic potential in lipid disorders is warranted.